Stability and Formulation of Erlotinib in Skin Creams
- Supplementary File 1:
ZIP-Document (ZIP, 359 KiB)
Nguyen, D.; Secrétan, P.-H.; Cotteret, C.; Jacques-Gustave, E.; Greco, C.; Bodemer, C.; Schlatter, J.; Cisternino, S. Stability and Formulation of Erlotinib in Skin Creams. Molecules 2022, 27, 1070. https://doi.org/10.3390/molecules27031070
Nguyen D, Secrétan P-H, Cotteret C, Jacques-Gustave E, Greco C, Bodemer C, Schlatter J, Cisternino S. Stability and Formulation of Erlotinib in Skin Creams. Molecules. 2022; 27(3):1070. https://doi.org/10.3390/molecules27031070
Chicago/Turabian StyleNguyen, David, Philippe-Henri Secrétan, Camille Cotteret, Emmanuelle Jacques-Gustave, Céline Greco, Christine Bodemer, Joel Schlatter, and Salvatore Cisternino. 2022. "Stability and Formulation of Erlotinib in Skin Creams" Molecules 27, no. 3: 1070. https://doi.org/10.3390/molecules27031070